chrisvoncsefalvay/vaers-outcomes huggingface dataset:
2 days after immunizations - 7 by 3 cm of erythema, slight induration and warmth to touch. Cramping of ventral surface of forearm for 1 -2 minutes, intervals and slight discomfort of middle finger - no skin changes of forearm/fingers. Afebrile - 37.2. Tx - Ibuprofen, elevation, packs warm.
Day 4 I had sinus problems, swollen left lymph node in neck , back pain. Day 2 I itched everywhere, mainly my neck, stomach and back Day 10 Left eye is swollen and pain on eyelid and behind eye lid
PELVIC INFLAMMATION; LITTLE URINARY TRACT INFECTION; NEGATIVE UNUSUAL SIDE EFFECTS; This spontaneous report received from a patient concerned a 71 year old female. The patient's height, and weight were not reported. No past history was reported. Patient's concurrent conditions included: food allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203A21A, and expiry: 23-JUN-2021) were not reported, 1 total, dose was not reported, administered on 12-APR-2021 for prophylactic vaccination on right arm (patient's vaccination card says her left arm). No concomitant medications were reported.  On an unspecified date, patient experienced negative unusual side effects after the vaccine but she did not want to report that as she could not attribute those side effects to the vaccine. patient got a little Urinary tract infection (UTI) and pelvic inflammation. Patient did not go to the emergency room (ER) or to her Doctor for that. She thought she might had an infection or something before that caused those side effects. Patient mentioned the exact day after she got the shot Johnson and Johnson was paused and she was watching for any side effects of clots or reproductive organs problems. It took her body a couple of months to return to normal. She did not have any pain in the arm where she got the shot and it was an easy shot. She thought they used short syringe. She did not feel any more tired than she would feel from normal environmental factors. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from negative unusual side effects, little urinary tract infection, and pelvic inflammation. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:20210935083-COVID-19 VACCINE AD26.COV2.S-Pelvic inflammation. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
He got his vaccine, everyting was OK, he went home.  He had some reaction to it, lethargy, fever, headache and that was pretty much for that and lasted for a day.  Then on 12/30/22 he was sitting on the couch, watching TV and the next thing he knows he was on the floor, had passed out. He had trouble getting up and after he got up he was spaced out, could not figure out how to use his cell phone, was trying to call 9-1-1 with the TV remote and really out of it.  Things started coming around and was able to call 9-1-1 and call his wife.  He was taken to the hospital, checked him out.  They did an MRI, sent him home and then after the next day they called him up and told him to come back to the hospital. They told him that he had had 3 strokes, all at the same time.  They were pretty much minor strokes, but has bad weakness to the right arm, some limp and due to this the DMV took his drivers license and not able to drive, not able to work and as he was 62 decided to retire.  He then saw a neurologist on 12/30/22 at the local ER. A Dr. at Neurology Dept.  He asked him in the ER if this could have been caused by the COVID shot, but he did not want to say but told him that it was possible.  He is now on a baby aspirin as a blood thinner and he continues to take his BP medicines.   He went to the ER at hospital locally initially.
Flu like symptoms - pain all over, and at injection site, headache I am reporting this because my 4 yr 1 mo old son who breastfeeds spiked a fever around the same time as my symptoms began. He has no other symptoms. The fever has risen to 102.4. I will bring him to the doctor in the morning if it continues and he shows other signs of illness.
Information has been received from a licensed practical nurse concerning a 24 month old female patient with no pertinent medical history and no drug reactions or allergies, who on 10-JUN-2010 was vaccinated with a dose of 0.5 milliliter subcutaneous of MMR II (Lot number not provided). Per child's mother, shortly after receiving the vaccine on 10-JUN-2010, ("by the time they got home from the office") the patient experienced numbness and tingling in the arm where injection was given and there was swelling from the site of injection down to the patient's wrist. The mother of the patient reported that all symptoms resolved by 12 am on 11-JUN-2010. The patient sought medical attention, the mother called to the physician office. No treatment was given for the adverse event. No laboratory diagnostics studies were performed. On 11 JUN 2010 at 12 pm, the patient recovered. Additional information has been requested.
tinnitus; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: TINNITUS (non-serious) with onset 2021, outcome "unknown", described as "tinnitus".  Additional information: The reporter enquired that Patient ok to restart series now, and go through both doses or should he look into the booster. If the Moderna vaccine is available, is it ok to get the Moderna vaccine or should he stick with Pfizer Covid vaccine. Has there been any link or heard of reports with tinnitus or ringing in the ear.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Second dose of Pfizer, I got the same reaction that many are reporting about the moderna. ?Covid arm? I had a bit of swelling, redness and large red circle around.
10/25/12 about 11:35 AM per patient report to pharmacy. 1st day (10/19/12) vomiting and terrible chills, chill lasted for 2 days then off and on until 10/24/12. 10/26/12 I called to check-up (left message). 10/27/12 Patient was shopping in the store per patient she is fine now.
Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050E21A) for COVID-19 vaccination.     No Medical History information was reported.    In November 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  Date the vial was initially stored in the refrigerator was 04-Nov-2021 and the vial did not undergo any temperature excursions. It was reported that, some patients took dose on 05-Nov-2021 and the other patients took dose on 12-Nov-2021.  The patient did not experience any events, because of this misadministration.  No treatment information was provided by the reporter.
Red, flat, itchy rash on stomach, face, arms and legs. Afebrile. Mother applies Neosporin ointment to rash.
Constipation on Wed 6/20. Dry heaves, some diarrhea, unknown fever began Friday and Saturday. No problems on Sunday 6/24 (spoke to pt 1 pm).
Rash on thigh, arms and stomach.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 74 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 07Sep2021 11:30 (Lot number: 7C 3184) at the age of 74 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Prostate cancer" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: RASH (non-serious) with onset 08Sep2021 07:30, outcome "recovering", described as "Rash on thigh, arms and stomach.". Therapeutic measures were taken as a result of rash.  Additional information: Facility type vaccine was Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had no known allergies. Treatment included, Benadryl.  Follow-up attempts are completed. No further information is expected.
on the afternoon of 2/10/2022, I started to develop a sore throat. When I woke up the next morning the sore throat was still there, but I had no other symptoms at the time  -- because I'm a medical student on my pediatric rotation I did not want to risk exposing kids so I called out. I went to an urgent care that same morning and received a rapid strep and covid test, both of which were negative. The PA that examined me didn't see any objective signs of illness on the exam. He took a swab for the covid PCR test and told me to quarantine until the results came back. Around noon that same day, I developed muscle aches and joint pain. I took ibuprofen. The next day the muscle/joint pains were worse, I was very fatigued with poor appetite, and I had a cough. I alternated ibuprofen and tylenol. Sunday, I had no longer had muscle aches, but I was still fatigued and had a cough, congestion, and sore throat. Monday, symptoms slightly improved. Tuesday, continued improvement. And today 2/16, I still have a cough, but overall feel much better
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 77-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 16Sep2022 at 10:00 as dose 4 (booster), single (Lot number: GH9702) at the age of 76 years, in right arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 04Feb2021 as dose 1, single (Lot number: C19265), in right arm, on 27Feb2021 as dose 2, single (Lot number: EN6203) and on 07Oct2021 as dose 3 (booster), single (Lot number: EW0191), in right arm for covid-19 immunisation. The patient's relevant medical history included: "season allergy" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Mar2023, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were not taken as a result of vaccination failure, covid-19.  Clinical course: Patient was not taking any other medications products within 2 weeks of starting COVID-19 treatment.
Pt's wife called on 10/17/18 stating that the patient was having chills and slight body aches. We advised her to give him an OTC pain reliever such as TYLENOL. They came in to the store 10/19/18 (today) stating that patient is having an allergic reaction to the PREVNAR vaccine. We stepped into the consultation room so I could see pt's arm. Pt's had a large red rash that extended down towards his elbow. He said he had already taken BENADRYL. I advised pt to go to a minor med as his rash looked like an allergic reaction. Later tonight, we received Rxs for antibiotic, steroid pack and BENADRYL. As of this report, he has not returned to pick them up.
Vaccination site rash; Arthritic pains; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Vaccination site rash) and ARTHRALGIA (Arthritic pains) in an adult female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced VACCINATION SITE RASH (Vaccination site rash) and ARTHRALGIA (Arthritic pains). At the time of the report, VACCINATION SITE RASH (Vaccination site rash) had resolved and ARTHRALGIA (Arthritic pains) was resolving.        The action taken with mRNA-1273 (Spikevax) (Intramuscular) was unknown.       No Concomitant medication reported.  The reporter's causality for the event(s) of PATIENT DEVELOPED RASH FROM MODERNA VACCINE with HUMIRA(ADALIMUMAB) was a reasonable possibility. The reporter's causality for the event(s) of RHEUMATOID ARTHRITIS PAIN was not provided.  No Treatment medication reported.   Reporter did not allow further contact
Left deltoid - erythema/increased, warm to touch, mild tenderness. Tx: cold/ice pack/BENADRYL/OTC NSAIDs.
Within minutes of recieving immunizations patient became pale and diaphoretic while sitting.  Nurse was next to patient monitoring for any adverse effects and placed a cool wash cloth, fan and assisted patient into a lying position with his legs up.  This episode took approximately 20 minutes for patient to recover to a standing position.  Sibling also responded the same to similar immunization administration during this time.
I experienced peripheral neuropathy, burning and tingling in my feet/hands, and itching all over my body (internally). I went in for my regular physical and my doctor found that I'm pre-diabetic and high cholesterol. She asked when I took the vaccine and stated that my symptoms were onset by the vaccine from information she reviewed previously in articles for certain individuals. My symptoms have been happening since 06/014/2021. She put me on three tablets per day of Gabapentin for my symptoms and Crestor to lower my cholesterol.
Patient reported feeling dizzy, nauseated, and appeared pale Patient stated not eating before coming for appointment Patient provided with water and food, and seen by medical team Patient stated symptoms improved after eating and drinking Patient refused medical transport and signed AMA form
"Patient with 2 Moderna COVID vaccinations, last dose 07/12/21 who admitted with COVID complications.  Provider discharge note below:  "Reason for Admission: 69 yo female with pmhx ADHD, asthma, chronic resp failure on 2L at home from COPD, dementia, HTN, IBS, left hemiparesis admitted with COVID pneumonia and COPD exacerbation.   Brief Summary of Hospital Stay: Pt improved with supportive care, steroids, aerosol therapy, doxy, and remdesivir. She is back to her baseline and eager to go home. I recommended that she stay to complete the complete remdesivir course, she declines in favor of going home, I explained the risks that she may get worse without it and this could be life threatening. She will continue to use her home oxygen at 2L and home ventilator as directed. She will see pulmonology this month and agrees to see PCP ASAP. "
FEVER; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced fever. Laboratory data (dates unspecified) included: Body temperature (: not provided) 37-39. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fever. This report was non-serious.
Chills two hours 99-102.5 fever 36 hours Body aches 48 hours Headache 24 hours Tightness in chest 30 minutes  Sore arm ongoing Redness and warmth in arm 36 hours after vaccine  Nausea 24 hours
HOSPITALIZATION - 11/27/21 TO 12/11/21: BREAKTHROUGH COVID-19 CASE
UTI/ bladder infection; Bladder infection; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (UTI/ bladder infection) and CYSTITIS (Bladder infection) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     The patient's past medical history included UTI since an unknown date. Concomitant products included NITROFURANTOIN for an unknown indication.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced URINARY TRACT INFECTION (UTI/ bladder infection) and CYSTITIS (Bladder infection). At the time of the report, URINARY TRACT INFECTION (UTI/ bladder infection) and CYSTITIS (Bladder infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sore throat; Weakness; Sore muscles in neck and shoulder; Loss of appetite; Exhaustion; Runny nose; Heart palpitations; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 14Apr2021 at 09:30 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, and too many allergies which were not specified. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included levothyroxine, liothyronine (NP THYROID), estradiol (ESTROGEN) and curcumin (MANUFACTURER UNKNOWN); all from unknown date for unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 24Mar2021 at 09:30 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Apr2021, the patient experienced sore throat, weakness, sore muscles in neck and shoulders, loss of appetite, exhaustion, runny nose, heart palpitations. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore throat, weakness, sore muscles in neck and shoulders, loss of appetite, exhaustion, runny nose, heart palpitations was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
She could not make her second appointment of 22Feb2021 to receive her second dose of the vaccine; Tested positive for the COVID-19 virus; Some congestion; Digestive system was messed up for one day; Slight fever, 100.5 degrees Fahrenheit; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for the COVID-19 virus), NASAL CONGESTION (Some congestion), DYSPEPSIA (Digestive system was messed up for one day), PRODUCT DOSE OMISSION ISSUE (She could not make her second appointment of 22Feb2021 to receive her second dose of the vaccine) and PYREXIA (Slight fever, 100.5 degrees Fahrenheit) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 02-Feb-2021.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Feb-2021, the patient experienced PYREXIA (Slight fever, 100.5 degrees Fahrenheit). On 02-Feb-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for the COVID-19 virus), NASAL CONGESTION (Some congestion) and DYSPEPSIA (Digestive system was messed up for one day). On 22-Feb-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (She could not make her second appointment of 22Feb2021 to receive her second dose of the vaccine). On 22-Feb-2021, PRODUCT DOSE OMISSION ISSUE (She could not make her second appointment of 22Feb2021 to receive her second dose of the vaccine) had resolved. At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for the COVID-19 virus) and DYSPEPSIA (Digestive system was messed up for one day) had resolved and NASAL CONGESTION (Some congestion) and PYREXIA (Slight fever, 100.5 degrees Fahrenheit) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Feb-2021, Body temperature increased: 100.5 (High) 100.5. On 02-Feb-2021, COVID-19: positive (Positive) Positive.         The patient had her 2nd dose of moderna vaccine on april2021 and was reported  that she did not have any side effects from her second vaccination.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: No specific follow-up information recorded.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. The possible exposure to COVID-19 virus was a strong confounder.